Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

KRAS

  • Open Access
    Prognostic Value of KRAS Exon-specific Mutations in Patients With Colorectal Cancer
    KENTARO ASAKO, TAMURO HAYAMA, YOJIRO HASHIGUCHI, TOSHIYA MIYATA, YOSHIHISA FUKUSHIMA, RYU SHIMADA, KENSUKE KANEKO, KEIJIRO NOZAWA, KEIJI MATSUDA and TAKEO FUKAGAWA
    Anticancer Research April 2023, 43 (4) 1563-1568; DOI: https://doi.org/10.21873/anticanres.16306
  • Open Access
    Cancer Spheroid Proliferation Is Suppressed by a Novel Low-toxicity Compound, Pyra-Metho-Carnil, in a Context-independent Manner
    KAZUMASA YOSHIDA, KENSUKE NISHI, SHUHEI ISHIKURA, KAZUHIKO NAKABAYASHI, RYO YAZAKI, TAKASHI OHSHIMA, MASAHIKO SUENAGA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA
    Anticancer Research August 2022, 42 (8) 3993-4001; DOI: https://doi.org/10.21873/anticanres.15895
  • You have access
    Growth Suppression of Cancer Spheroids With Mutated KRAS by Low-toxicity Compounds from Natural Products
    SAYURI HASHIMOTO, MASAYOSHI NAGAI, KENSUKE NISHI, SHUHEI ISHIKURA, KAZUHIKO NAKABAYASHI, RYO YAZAKI, TAKASHI OHSHIMA, MASAHIKO SUENAGA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA
    Anticancer Research August 2021, 41 (8) 4061-4070; DOI: https://doi.org/10.21873/anticanres.15207
  • You have access
    Radiogenomic and Deep Learning Network Approaches to Predict KRAS Mutation from Radiotherapy Plan CT
    BUM-SUP JANG, CHANGHOON SONG, SUNG-BUM KANG and JAE-SUNG KIM
    Anticancer Research August 2021, 41 (8) 3969-3976; DOI: https://doi.org/10.21873/anticanres.15193
  • You have access
    Mutant KRAS Promotes NKG2D+ T Cell Infiltration and CD155 Dependent Immune Evasion
    KENSUKE NISHI, SHUHEI ISHIKURA, MASAYO UMEBAYASHI, TAKASHI MORISAKI, TAKASHI INOZUME, TETSUSHI KINUGASA, MIKIKO AOKI, SATOSHI NIMURA, ANTHONY SWAIN, YOICHIRO YOSHIDA, SUGURU HASEGAWA, KAZUKI NABESHIMA, TOSHIFUMI SAKATA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA
    Anticancer Research August 2020, 40 (8) 4663-4674; DOI: https://doi.org/10.21873/anticanres.14465
  • You have access
    MK615 Suppresses Hypoxia Tolerance by Up-regulation of E-cadherin in Colorectal Cancer Cells With Mutant KRAS
    KENSUKE NISHI, TOSHIYUKI TSUNODA, YOSHINORI UCHIDA, TAKAYUKI SUETA, MOTOHIRO SAWATSUBASHI, TAKAFUMI YAMANO, YASUKO HASHIGUCHI, ANTHONY SWAIN, SENJI SHIRASAWA and TOSHIFUMI SAKATA
    Anticancer Research August 2020, 40 (8) 4687-4694; DOI: https://doi.org/10.21873/anticanres.14468
  • You have access
    Secretin-induced Duodenal Aspirate of Pancreatic Juice (SIDA): Utility of Commercial Genetic Analysis
    RACHEL E. SIMPSON, MICHELE YIP-SCHNEIDER, KATELYN F. FLICK, MAZHAR SOUFI, EUGENE P. CEPPA, MOHAMMAD A. AL-HADDAD, JEFFREY J. EASLER, STUART SHERMAN, JOHN M. DEWITT and C. MAX SCHMIDT
    Anticancer Research August 2020, 40 (8) 4215-4221; DOI: https://doi.org/10.21873/anticanres.14422
  • You have access
    Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective Analysis
    LETIZIA GIANONCELLI, GIANLUCA SPITALERI, ANTONIO PASSARO, DAVIDE RADICE, CATERINA FUMAGALLI, ESTER DEL SIGNORE, VALERIA STATI, CHIARA MATILDE CATANIA, ELENA GUERINI-ROCCO, MASSIMO BARBERIS and FILIPPO DE MARINIS
    Anticancer Research January 2020, 40 (1) 427-433; DOI: https://doi.org/10.21873/anticanres.13970
  • You have access
    Microsatellite Instability in Greek Colorectal Carcinoma Patients: Clinicopathological and Molecular Correlations
    PATROKLOS KATAFYGIOTIS, STRATIGOULA SAKELLARIOU, ILENIA CHATZIANDREOU, IOANNA GIANNOPOULOU, IRENE THYMARA, ANGELICA A. SAETTA and PENELOPE KORKOLOPOULOU
    Anticancer Research November 2019, 39 (11) 6379-6387; DOI: https://doi.org/10.21873/anticanres.13851
  • You have access
    The Role of KRAS in Endometrial Cancer: A Mini-Review
    MICHAIL SIDERIS, ELIF ILIRIA EMIN, ZIENA ABDULLAH, JOHN HANRAHAN, KONSTANTINA MARIA STEFATOU, VASILEIOS SEVAS, ECE EMIN, TONY HOLLINGWORTH, FUNLAYO ODEJINMI, SAVVAS PAPAGRIGORIADIS, SOTIRIS VIMPLIS and FREDRIC WILLMOTT
    Anticancer Research February 2019, 39 (2) 533-539; DOI: https://doi.org/10.21873/anticanres.13145

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire